- Home
- STKH vs NCNA Comparison
STKH vs NCNA Comparison
Compare STKH & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKH
- NCNA
- Stock Information
- Founded
- STKH 2018
- NCNA 1997
- Country
- STKH Israel
- NCNA United Kingdom
- Employees
- STKH N/A
- NCNA N/A
- Industry
- STKH Packaged Foods
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- STKH Consumer Staples
- NCNA Health Care
- Exchange
- STKH Nasdaq
- NCNA Nasdaq
- Market Cap
- STKH 4.6M
- NCNA 4.3M
- IPO Year
- STKH 2021
- NCNA 2017
- Fundamental
- Price
- STKH $1.60
- NCNA $1.14
- Analyst Decision
- STKH
- NCNA Buy
- Analyst Count
- STKH 0
- NCNA 2
- Target Price
- STKH N/A
- NCNA $25.00
- AVG Volume (30 Days)
- STKH 41.5K
- NCNA 238.3K
- Earning Date
- STKH 08-30-2024
- NCNA 11-25-2024
- Dividend Yield
- STKH N/A
- NCNA N/A
- EPS Growth
- STKH N/A
- NCNA N/A
- EPS
- STKH N/A
- NCNA N/A
- Revenue
- STKH N/A
- NCNA N/A
- Revenue This Year
- STKH N/A
- NCNA N/A
- Revenue Next Year
- STKH N/A
- NCNA N/A
- P/E Ratio
- STKH N/A
- NCNA N/A
- Revenue Growth
- STKH N/A
- NCNA N/A
- 52 Week Low
- STKH $1.43
- NCNA $0.96
- 52 Week High
- STKH $7.70
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- STKH 40.05
- NCNA 43.15
- Support Level
- STKH $1.50
- NCNA $0.96
- Resistance Level
- STKH $1.70
- NCNA $1.37
- Average True Range (ATR)
- STKH 0.16
- NCNA 0.15
- MACD
- STKH 0.02
- NCNA -0.00
- Stochastic Oscillator
- STKH 38.89
- NCNA 26.09
About STKH Steakholder Foods Ltd.
Steakholder Foods Ltd is a deep-tech food company. The company is cultivating meat technologies to improve meat production, simplify the meat supply chain, and offer consumers a range of new product offerings. The company aims to provide an alternative to industrialized animal farming that reduces carbon footprint, minimizes water and land usage, and prevents the slaughtering of animals. It is developing a novel, proprietary three-dimensional bioprinter for three-dimensional printing of meat and seafood analogs, followed by hybrid meats that combine cultivated and plant-based elements.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.